APYX News and Press, Apyx Medical Corporation From 04/04/22

Apyx Medical (NASDAQ:APYX) submitted a 510(k) premarket notification to the U.S. Food and Drug Administration for expanding the use of Renuvion APR Handpiece to improve the appearance of lax (loose) skin in the neck and submental region. The application is aimed at expanding Renuvion APR Hand...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic surgery market and J-Plasma ® in the hospital surgical marke...

Apyx Medical Corporation (APYX) Q4 2021 Earnings Conference Call March 17, 2022, 8:00 AM ET Company Participants Charles Goodwin – President, Chief Executive Officer & Director Tara Semb – Chief Financial Officer, Treasurer & Secretary Conference Call Participants Matthe...

Apyx Medical press release (NASDAQ:APYX): Q4 GAAP EPS of -$0.06 beats by $0.05. Revenue of $16.82M (+46.3% Y/Y) beats by $0.47M. Full Year 2022 Financial Outlook: Total revenue in the range of $50.0 million to $63.0 million vs consensus of $59.91M, representing growth of 3% to 30% year-o...

Advanced Energy Sales increased 52% year-over-year in Q4; up 94% year-over-year in 2021 Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold ...

Medical device maker Apyx Medical Corporation (APYX -21.2%) is trading sharply lower on Monday after the company warned that the U.S. Food and Drug Administration (FDA) flagged potential safety issues linked to its Advanced Energy products. According to Apyx (NASDAQ:APYX), the FDA has issued ...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic surgery market and J-Plasma ® in the hospital surgical marke...

Announces Additional FDA 510(k) Submission for the Use of the Renuvion ® Dermal Handpiece in Dermatological Procedures Requiring Ablation and Resurfacing of the Skin Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices...

Arenberg Capital initiates coverage of InMode stock with hold rating prior to the company's FY21 earnings on February 10, 2022. We ran multiple approaches to determine the fair valuation of this high-growth medtech company. Our DCF indicates a fair valuation at the current price l...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today a...